← Back to Search

Contact Lenses

All participants received Biotrue ONEday lenses with and without an alternate packaging solution for Contact Lens User

N/A
Waitlist Available
Led By Jeffery Schafer, OD
Research Sponsored by Bausch & Lomb Incorporated
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 2 hours
Awards & highlights

Summary

The objective of this 2 hour study is to evaluate the clinical performance of Biotrue ONEday lenses with an alternate packaging solution (EPG03) compared to commercially available Biotrue ONEday lenses. This novel contact lens packaging solution contains known elements in the ophthalmic industry and is safe for use.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~2 hours
This trial's timeline: 3 weeks for screening, Varies for treatment, and 2 hours for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Normalized logMAR Visual Acuity

Trial Design

1Treatment groups
Experimental Treatment
Group I: All participants received Biotrue ONEday lenses with and without an alternate packaging solutionExperimental Treatment1 Intervention
Participants were given both Commercially available Biotrue ONEday lenses and Biotrue ONEday Contact Lenses with EPG03 Packaging Solution. Lens material is made from a hydrophilic copolymer of 2- hydroxyethyl methacrylate and N-vinylpyrrolidone and is 78% water by weight when immersed in saline solution. EPG03 Packaging Solution contains a phosphate buffered saline solution containing potassium chloride, poloxamine, poloxamer 181, glycerol (glycerin), erythritol, and polyquaternium-1.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
All participants received Biotrue ONEday lenses with and without an alternate packaging solution (EPG03)
2021
N/A
~40

Find a Location

Who is running the clinical trial?

Bausch & Lomb IncorporatedLead Sponsor
257 Previous Clinical Trials
58,197 Total Patients Enrolled
Jeffery Schafer, ODPrincipal InvestigatorBausch & Lomb Incorporated
5 Previous Clinical Trials
260 Total Patients Enrolled
~8 spots leftby Oct 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top